SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-179829
Filing Date
2021-06-02
Accepted
2021-06-02 16:02:39
Documents
15
Period of Report
2021-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d184678d8k.htm   iXBRL 8-K 48068
2 EX-3.1 d184678dex31.htm EX-3.1 6993
3 EX-10.1 d184678dex101.htm EX-10.1 130826
4 EX-10.2 d184678dex102.htm EX-10.2 108440
  Complete submission text file 0001193125-21-179829.txt   493363

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA zgnx-20210527.xsd EX-101.SCH 3093
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zgnx-20210527_lab.xml EX-101.LAB 18889
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zgnx-20210527_pre.xml EX-101.PRE 11875
8 EXTRACTED XBRL INSTANCE DOCUMENT d184678d8k_htm.xml XML 3556
Mailing Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 (510) 550-8300
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34962 | Film No.: 21989069
SIC: 2834 Pharmaceutical Preparations